home / stock / blu:cc / blu:cc quote
Last: | $12.46 |
---|---|
Change Percent: | 1.8% |
Open: | $12.24 |
Close: | $12.24 |
High: | $12.55 |
Low: | $12.07 |
Volume: | 95,564 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$12.46 | $12.24 | $12.24 | $12.55 | $12.07 | 95,564 | 08-02-2022 |
$9.93 | $10.69 | $9.93 | $10.69 | $9.87 | 170,067 | 05-06-2022 |
$10.72 | $11.18 | $10.72 | $11.26 | $10.36 | 195,688 | 05-05-2022 |
$11.23 | $11.15 | $11.23 | $11.29 | $10.64 | 150,992 | 05-04-2022 |
$11.16 | $11.5 | $11.16 | $11.68 | $11.03 | 163,671 | 05-03-2022 |
$11.55 | $10.26 | $11.55 | $11.56 | $10.26 | 192,577 | 05-02-2022 |
$10.32 | $10.14 | $10.32 | $10.48 | $10.11 | 84,657 | 04-29-2022 |
$10.26 | $10.45 | $10.26 | $10.52 | $9.63 | 144,880 | 04-28-2022 |
$10.35 | $10.99 | $10.35 | $11.27 | $10.2 | 170,805 | 04-27-2022 |
$10.97 | $11.13 | $10.97 | $11.25 | $10.63 | 191,336 | 04-26-2022 |
$11.14 | $10.39 | $11.14 | $11.21 | $10.2 | 146,999 | 04-25-2022 |
$10.46 | $10.16 | $10.46 | $10.52 | $9.85 | 235,436 | 04-22-2022 |
$10.17 | $10.79 | $10.17 | $11.31 | $10.11 | 239,640 | 04-21-2022 |
$10.81 | $10.53 | $10.81 | $11 | $10.39 | 180,296 | 04-20-2022 |
$10.58 | $10.3 | $10.58 | $10.6 | $10.2 | 90,537 | 04-19-2022 |
$10.3 | $10.49 | $10.3 | $10.49 | $10.1 | 189,412 | 04-18-2022 |
$10.44 | $10.47 | $10.44 | $10.47 | $10.08 | 137,583 | 04-15-2022 |
$10.44 | $10.47 | $10.44 | $10.47 | $10.08 | 136,145 | 04-14-2022 |
$10.51 | $10.29 | $10.51 | $10.6 | $10.22 | 206,800 | 04-13-2022 |
$10.29 | $10.29 | $10.29 | $10.51 | $10.16 | 196,211 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Bellus Health Inc. Company Name:
BLU:CC Stock Symbol:
TSXC Market:
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON , June 28, 2023 /CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed ...
2023-06-27 18:45:00 ET Early investors in Canadian biotech stock BELLUS Health ( TSX:BLU ) could be ecstatic right now after a fine 75.5% rally in BLU stock year to date. The bullish run was ensued after global pharmaceuticals giant GSK offered to acquire all BELLUS stock at...
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“ BELLUS ” or the “ Company ”) today announced the positive outcome of the BELLUS shareholders (“ Shareholders ”) vote at this morning’s special meeting of the Shareholders (the “ ...